Blueprint Medicines
At close: Nov 25(Delayed 15-Minutes)
Get Real Time Here
After Hours: 1:01PM EDT
Day Range44.15 - 45.1752 Wk Range40.78 - 110.23Open / Close44.32 / 44.89Float / Outstanding59.5M / 59.8M
Vol / Avg.173.5K / 722.5KMkt Cap2.7BP/E-50d Avg. Price53.86
Div / Yield-Payout Ratio-Total Float59.5MEPS-2.23

Blueprint Medicines Stock (NASDAQ:BPMC), Earnings Estimates, EPS, and Revenue

Blueprint Medicines reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 1



Quarterly Revenue


Annual Revenue (as of Sep 30)


Earnings Recap

Blueprint Medicines (NASDAQ:BPMC) reported its Q3 earnings results on Tuesday, November 1, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.


Blueprint Medicines beat estimated earnings by 10.44%, reporting an EPS of $-2.23 versus an estimate of $-2.49.

Revenue was up $41.79 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.45 which was followed by a 6.06% increase in the share price the next day.

Here's a look at Blueprint Medicines's past performance:


Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -2.23 -1.94 -1.65 -1.63
EPS Actual -2.68 -1.79 -0.99 -2
Revenue Estimate 37.24M 36.65M 102.69M 42.47M
Revenue Actual 36.55M 62.73M 107.02M 24.19M

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings History

Analyze the earnings history of Blueprint Medicines using advanced sorting and filters.

Prior EPS
Actual EPS
EPS Surprise
Prior Rev
Est Rev
Actual Rev
Rev Surprise
Get Alert

When is Blueprint Medicines (NASDAQ:BPMC) reporting earnings?


Blueprint Medicines (BPMC) is scheduled to report earnings on February 15, 2023. The last reported earnings were for reported on November 1, 2022 for Q3.


What were the latest earnings per share (EPS) for Blueprint Medicines (NASDAQ:BPMC)?


The Actual EPS was $-1.23, which missed the estimate of $0.00.


What were Blueprint Medicines’s (NASDAQ:BPMC) revenues?


The Actual Revenue was $1.6M, which beat the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.